Reddy et al. (128) found that high doses of curcumin in letrozole-induced PCOS model rats could restore the estradiol concentrations reduced by aromatase inhibitors, further validating the phytoestrogen properties of curcumin (149). Here, CYP19A1 is linked to polycystic ovary syndrome.